Psyence Biomedical Ltd. PBM 深 沪
等待开盘 04-01 09:30:00 美东时间
2.46
-0.060
-2.38%
华盛通- 最 高2.4903
- 今 开2.4847
- 成交量 4047股
- 最 低 2.4101
- 昨 收 2.52
- 总市值 282.19万
- 52周最高 74.9375
- 市盈率 静 0.22
- 换手率 0.35%
- 52周最低 1.92
- 委 比 -83.01%
- 总股本 114.71万
- 历史最高 392.0244
- 量 比 0.23
- 振 幅 3.18%
- 历史最低 2.4101
- 每 手 1
- 风险率 12.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
Psyence Biomedical Ltd. has strengthened its position in the psychedelic pharmaceutical sector through its investment in PsyLabs, securing licensed production, supply chains, and GMP-compliant manufacturing. The partnership enhances the company's infrastructure for clinical and commercial scalability, reducing execution risks and supporting long-term growth. With no corporate debt and a disciplined capital allocation strategy, Psyence Biomedical ...
03-11 13:15
Psyence Biomedical Announces Export Of Fully GMP-Compliant Manufactured Psilocybin Product NPX-5 To Australia
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the
03-03 22:17
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial
Psyence Biomedical Ltd. successfully exported GMP-compliant psilocybin product NPX-5 to Australia for its Phase IIb clinical trial targeting Adjustment Disorder in cancer patients. This shipment highlights the company's operational readiness and commitment to establishing a regulated global supply chain. The trial, involving 87 participants, evaluates natural psilocybin's efficacy in reducing anxiety and depression. The export demonstrates Psyenc...
03-03 14:15
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Vir Biotechnology (NASDAQ:VIR) shares moved upwards by 65.0% to $12.26...
02-24 20:05
Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket
Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose sharply in pre-market t...
02-23 17:57
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers CytoMed Therapeutics (NASDAQ:GDTC) shares moved upwards by 6.9% to $1....
02-14 05:06
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway
Psyence BioMed has entered into a Put Option Agreement with PsyLabs, a leading developer and manufacturer of pharmaceutical-grade psychedelic compounds, to secure predictable and reliable supply of psychedelics for its clinical and commercial programs. The agreement allows Psyence BioMed to acquire a significant equity stake in PsyLabs as its development evolves, while preserving near-term financial flexibility. PsyLabs, recognized for its scalab...
02-13 23:30
Psyence BioMed Announces Settlement of Shareholder Litigation
Psyence BioMed与KAOS Capital达成和解协议，Psyence BioMed将支付150万美元，KAOS同意出售其所持股份，指控被撤回。和解不具认罪性质，公司否认指控，为避免诉讼成本与干扰选择和解。
02-11 14:15
Why Teradyne Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Shares of Teradyne Inc (NASDAQ:TER) rose sharply in pre-market trading after th...
02-03 17:42
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026
Psyence Biomedical Ltd. has postpone its annual and special shareholder meeting until February 12, 2026, due to insufficient shareholder quorum. The meeting will take place in Cape Town, South Africa. The company is working with proxy agents to ensure quorum for the reconvened meeting. The record date remains December 23, 2025. Psyence BioMed is a biopharmaceutical company developing nature-derived psychedelic medicines for mental health treatmen...
01-22 18:42
